This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
🫁 Airway Clearance in Aspergillosis: A Patient Guide
July 16, 2025
Biologics and Long Term Side Effects
July 14, 2025
🛡️ FFP2/FFP3 Mask Use in Aspergillosis: Summary
July 11, 2025
News archive
- Air pollution
- Allergy or Intolerance
- Antifungals in development
- Antimicrobial resistance
- COVID-19
- Climate change
- Diagnostics
- Events
- Fundraising
- GP Guidance
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- NHS
- News archive
- Palliative care
- Patient and Carer Blog
- Patient stories
- Professional Guidance
- Questions
- Recordings
- Research
- Research Summaries
- Supplements and complementary therapies
- Travel
- Treatment
- Types of aspergillosis
- Video